MENU
NVAX
AS OF
Dec 24 closing price
Price
$6.94
Change
+$0.14 (+2.06%)
Capitalization
1.13B
69 days until earnings call
Intraday BUY SELL Signals
OUR PRODUCTS
MOBILE APPS
GENERAL INFO
Help
© 2013-2025 All rights reserved. Tickeron Inc.
NVAX
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Novavax (NVAX) Ownership - Who owns Novavax?

Novavax Inc is a biotechnology company that develops vaccines... Show more

Industry: #Biotechnology
#MovingAverage#Momentum#MACD#Pattern#RSI#Stochastic#Aroon#Bollinger

Profile

Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
1.13B
P/E Ratio
3.45
Total Cash
762.89M
Projected Growth
N/A
Total Debt
251.14M
Revenue
1.06B
Risk (Beta)
3.18
Dividend Yield
N/A
Total Cash/Share
4.69
Total Debt/Equity
1.05
Revenue/Share
6.41 USD as % of share price

Fundamentals

NVAX
Capitalization
1.13B
P/E Ratio
3.45
Risk (Beta)
3.18
Dividend Yield
N/A
Total Cash
763M
Total Cash/Share
4.69
Total Debt
251M
Total Debt/Equity
1.05
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
6.41%
Revenue
1.07B
ROE
N/A
Book Value
-156.67M
P/B Ratio
33.22
Cash Flow
N/A
Earnings
2.09
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
1.65M
Current Ratio
2.27
Current Revenue Per Employee
208576.31
Dividends Per Share - Security
N/A
EBITDA
410M
Float
N/A
Float - Current
N/A
Gross Income Margin
69.49
Revenue To Assets
23.63
Shares Held By Institutions
1.15B
Shares Outstanding - Current
162M
Total Liabilities
1.34B
Total Volume MTD
N/A
Value
-1
Gain YTD
-13.682
View a ticker or compare two or three
GO
VS
Compare
VS
Compare
Day Trader: Search for Dip TA&FA ($1500)Day Trader: Search for Dip TA&FA ($1500)
Annualized Return+8%
VIEW DETAILSVIEW DETAILS
VIEW FOR FREEVIEW FOR FREE
NVAX
Setup
Setup
Daily Signal:
Description
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. NVAX showed earnings on November 06, 2025. You can read more about the earnings report here.
View AI-Driven Trading for NVAX
A.I. Advisor
published General Information

General Information

a company which engages in development of novel recombinant vaccines

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Biotechnology
Address
700 Quince Orchard Road
Phone
+1 240 268-2000
Employees
1534
Web
https://www.novavax.com